Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 22nd May 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 10, 2019
Previous Article Next Article

Smartphone-app based point-of-care testing for myocardial infarction biomarker cTnI using an autonomous capillary microfluidic chip with self-aligned on-chip focusing (SOF) lenses

Author affiliations

Abstract

Cardiovascular disease is one of the most common causes of mortality in the world. Most of the diagnostic processes usually require bulky instruments and trained professionals, which cannot meet the demand for fast, early and regular bedside diagnosis. In this paper, a bespoke app on a smartphone and an autonomous capillary microfluidic chip (ACMC) are combined to realize the point-of-care testing of cardiac troponin I (cTnI). The smartphone-app-ACMC platform was based on the sandwich immunofluorescence principle and featured self-aligned on-chip focusing (SOF) lenses which can avoid the complex optical coupling process. The operator only needs to introduce 100 μl sample into the ACMC, where the priming, time-delaying, mixing and washing steps for the assay can be accomplished automatically. With the help of the bespoke app and a palm-sized optical attachment, the smartphone can capture fluorescence images, process fluorescence intensity information, output detection results and save the results for long-term monitoring. Our results showed that within 12 min, the detection limit of 78 pg ml−1 and 94 pg ml−1 for cTnI was attained in buffer and spiked human serum, respectively. Our proposed platform has the potential to be applied in the POCT field especially for some resource-limited settings.

Graphical abstract: Smartphone-app based point-of-care testing for myocardial infarction biomarker cTnI using an autonomous capillary microfluidic chip with self-aligned on-chip focusing (SOF) lenses

Back to tab navigation

Supplementary files

Publication details

The article was received on 17 Mar 2019, accepted on 02 Apr 2019 and first published on 04 Apr 2019


Article type: Paper
DOI: 10.1039/C9LC00259F
Lab Chip, 2019,19, 1797-1807

  •   Request permissions

    Smartphone-app based point-of-care testing for myocardial infarction biomarker cTnI using an autonomous capillary microfluidic chip with self-aligned on-chip focusing (SOF) lenses

    C. Liang, Y. Liu, A. Niu, C. Liu, J. Li and D. Ning, Lab Chip, 2019, 19, 1797
    DOI: 10.1039/C9LC00259F

Search articles by author

Spotlight

Advertisements